[Latest] Global Hemophilia B Gene Therapy Market Size/Share Worth USD 5,938.5 Billion by 2032 at a 34.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
September 27, 2023 16:00 ET
|
Custom Market Insights
Austin, TX, USA, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hemophilia B Gene Therapy Market Size, Trends and Insights By Treatment Type...
EHang Strategically Invests in Solid-State Lithium Metal Battery Tech Company Inx to Develop Solid-State Battery Supply Chain for eVTOLs
September 20, 2023 07:26 ET
|
EHang Holdings Limited
GUANGZHOU, China, Sept. 20, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform...
Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval
September 13, 2023 03:00 ET
|
Rentschler Biopharma SE
UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapyHighly experienced team ready to support ATMP innovators at all stagesOffering comprehensive range of...
Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases
September 07, 2023 17:00 ET
|
Shape Therapeutics, Inc.; Otsuka
TOKYO and SEATTLE, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Otsuka Pharmaceutical Co., Ltd. (Otsuka) and ShapeTX, the programmable medicine company using AI and RNA to end genetic diseases, today announce...
EHang Unmanned Aircraft Cloud System Approved by the CAAC; EH216-S Positioned for Post-TC Commercial Operations
August 21, 2023 09:19 ET
|
EHang Holdings Limited
GUANGZHOU, China, Aug. 21, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...
EHang Reports Second Quarter 2023 Unaudited Financial Results
August 17, 2023 05:00 ET
|
EHang Holdings Limited
- All Planned Tests for EH216-S Type Certification Completed 100% - Strategic UAM Operational Partnership with Shenzhen Bao’an District - US$23 Million Strategic PIPE Investment to Strengthen...
Solve GNE and Genosera Sign Agreement to Develop a Novel Bicistronic AAV Gene Therapy Targeting HIBM
August 14, 2023 09:00 ET
|
Solve GNE LLC
LOS ANGELES, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Solve GNE announced today that it has entered into a sponsored research agreement with Genosera to provide funding for a novel Adeno-Associated Virus...
EHang to Report Second Quarter 2023 Unaudited Financial Results on Thursday, August 17, 2023
August 11, 2023 08:25 ET
|
EHang Holdings Limited
GUANGZHOU, China, Aug. 11, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...
EHang and Shenzhen Bao’an District Form Strategic Partnership for Urban Air Mobility Operation Center
July 13, 2023 08:32 ET
|
EHang Holdings Limited
GUANGZHOU, China, July 13, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...
EHang Announces US$23 Million Private Placement Led by South Korean Strategic Investor Lee Soo Man
July 11, 2023 16:00 ET
|
EHang Holdings Limited
GUANGZHOU, China, July 12, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...